A citation-based method for searching scientific literature

Charles A Hoeffer, Eric Klann. Trends Neurosci 2010
Times Cited: 762







List of co-cited articles
964 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
24

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
13

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
677
12

mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
11

A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus.
Shao Jun Tang, Gerald Reis, Hyejin Kang, Anne-Claude Gingras, Nahum Sonenberg, Erin M Schuman. Proc Natl Acad Sci U S A 2002
553
10

mTOR in Brain Physiology and Pathologies.
Joël Bockaert, Philippe Marin. Physiol Rev 2015
193
10

mTOR complexes in neurodevelopmental and neuropsychiatric disorders.
Mauro Costa-Mattioli, Lisa M Monteggia. Nat Neurosci 2013
212
10

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Nanxin Li, Rong-Jian Liu, Jason M Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Biol Psychiatry 2011
721
10

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
10

The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.
Courtney S Jernigan, Dharmendra B Goswami, Mark C Austin, Abiye H Iyo, Agata Chandran, Craig A Stockmeier, Beata Karolewicz. Prog Neuropsychopharmacol Biol Psychiatry 2011
259
9


Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1.
Maurizio Cammalleri, Robert Lütjens, Fulvia Berton, Alvin R King, Cindy Simpson, Walter Francesconi, Pietro Paolo Sanna. Proc Natl Acad Sci U S A 2003
234
8

Upstream and downstream of mTOR.
Nissim Hay, Nahum Sonenberg. Genes Dev 2004
8

The neurology of mTOR.
Jonathan O Lipton, Mustafa Sahin. Neuron 2014
388
8

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
8

BDNF release is required for the behavioral actions of ketamine.
Ashley E Lepack, Manabu Fuchikami, Jason M Dwyer, Mounira Banasr, Ronald S Duman. Int J Neuropsychopharmacol 2014
217
8

A recollection of mTOR signaling in learning and memory.
Tyson E Graber, Patrick K McCamphill, Wayne S Sossin. Learn Mem 2013
88
7

mTOR Signaling in Growth, Metabolism, and Disease.
Robert A Saxton, David M Sabatini. Cell 2017
7

Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.
Guomei Tang, Kathryn Gudsnuk, Sheng-Han Kuo, Marisa L Cotrina, Gorazd Rosoklija, Alexander Sosunov, Mark S Sonders, Ellen Kanter, Candace Castagna, Ai Yamamoto,[...]. Neuron 2014
575
7

Mechanisms of ketamine action as an antidepressant.
P Zanos, T D Gould. Mol Psychiatry 2018
313
7

Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism.
Kimberly M Huber, Eric Klann, Mauro Costa-Mattioli, R Suzanne Zukin. J Neurosci 2015
105
7

Molecular neurobiology of mTOR.
Katarzyna Switon, Katarzyna Kotulska, Aleksandra Janusz-Kaminska, Justyna Zmorzynska, Jacek Jaworski. Neuroscience 2017
189
7

Translational control of long-lasting synaptic plasticity and memory.
Mauro Costa-Mattioli, Wayne S Sossin, Eric Klann, Nahum Sonenberg. Neuron 2009
657
6

Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation.
Jacqueline Blundell, Mehreen Kouser, Craig M Powell. Neurobiol Learn Mem 2008
114
6

mTOR signaling in the hippocampus is necessary for memory formation.
Pedro Bekinschtein, Cynthia Katche, Leandro N Slipczuk, Lionel Müller Igaz, Martín Cammarota, Iván Izquierdo, Jorge H Medina. Neurobiol Learn Mem 2007
133
6

The growing role of mTOR in neuronal development and plasticity.
Jacek Jaworski, Morgan Sheng. Mol Neurobiol 2006
206
6

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.
Chadi G Abdallah, Lynnette A Averill, Ralitza Gueorguieva, Selin Goktas, Prerana Purohit, Mohini Ranganathan, Mohamed Sherif, Kyung-Heup Ahn, Deepak Cyril D'Souza, Richard Formica,[...]. Neuropsychopharmacology 2020
56
10


mTOR Signaling in Growth, Metabolism, and Disease.
Robert A Saxton, David M Sabatini. Cell 2017
969
6

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
235
6

Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease.
Tao Ma, Charles A Hoeffer, Estibaliz Capetillo-Zarate, Fangmin Yu, Helen Wong, Michael T Lin, Davide Tampellini, Eric Klann, Robert D Blitzer, Gunnar K Gouras. PLoS One 2010
182
5

LTP and LTD: an embarrassment of riches.
Robert C Malenka, Mark F Bear. Neuron 2004
5

Dysregulation of mTOR signaling in fragile X syndrome.
Ali Sharma, Charles A Hoeffer, Yukihiro Takayasu, Takahiro Miyawaki, Sean M McBride, Eric Klann, R Suzanne Zukin. J Neurosci 2010
400
5

Exercise increases mTOR signaling in brain regions involved in cognition and emotional behavior.
Brian A Lloyd, Holly S Hake, Takayuki Ishiwata, Caroline E Farmer, Esteban C Loetz, Monika Fleshner, Sondra T Bland, Benjamin N Greenwood. Behav Brain Res 2017
46
10

Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites.
Nobuyuki Takei, Naoko Inamura, Mihoko Kawamura, Hisaaki Namba, Kenta Hara, Kazuyoshi Yonezawa, Hiroyuki Nawa. J Neurosci 2004
326
5

Major depressive disorder.
Christian Otte, Stefan M Gold, Brenda W Penninx, Carmine M Pariante, Amit Etkin, Maurizio Fava, David C Mohr, Alan F Schatzberg. Nat Rev Dis Primers 2016
574
5

mTOR signaling and its roles in normal and abnormal brain development.
Nobuyuki Takei, Hiroyuki Nawa. Front Mol Neurosci 2014
186
5

Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
Bhavya Voleti, Andrea Navarria, Rong-Jian Liu, Mounira Banasr, Nanxin Li, Rose Terwilliger, Gerard Sanacora, Tore Eid, George Aghajanian, Ronald S Duman. Biol Psychiatry 2013
185
5

GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.
Oliver H Miller, Lingling Yang, Chih-Chieh Wang, Elizabeth A Hargroder, Yihui Zhang, Eric Delpire, Benjamin J Hall. Elife 2014
189
5

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Sungho Maeng, Carlos A Zarate, Jing Du, Robert J Schloesser, Joseph McCammon, Guang Chen, Husseini K Manji. Biol Psychiatry 2008
819
5

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
758
5

A neurotrophic model for stress-related mood disorders.
Ronald S Duman, Lisa M Monteggia. Biol Psychiatry 2006
5


Abnormal mTOR Activation in Autism.
Kellen D Winden, Darius Ebrahimi-Fakhari, Mustafa Sahin. Annu Rev Neurosci 2018
85
5

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.
Emma Puighermanal, Giovanni Marsicano, Arnau Busquets-Garcia, Beat Lutz, Rafael Maldonado, Andrés Ozaita. Nat Neurosci 2009
262
5

Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression.
Anteneh M Feyissa, Agata Chandran, Craig A Stockmeier, Beata Karolewicz. Prog Neuropsychopharmacol Biol Psychiatry 2009
258
5

mTOR signaling at a glance.
Mathieu Laplante, David M Sabatini. J Cell Sci 2009
5

Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice.
J Halloran, S A Hussong, R Burbank, N Podlutskaya, K E Fischer, L B Sloane, S N Austad, R Strong, A Richardson, M J Hart,[...]. Neuroscience 2012
146
5

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.
Dos D Sarbassov, Siraj M Ali, Shomit Sengupta, Joon-Ho Sheen, Peggy P Hsu, Alex F Bagley, Andrew L Markhard, David M Sabatini. Mol Cell 2006
5

Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD.
Sungjin Park, Joo Min Park, Sangmok Kim, Jin-Ah Kim, Jason D Shepherd, Constance L Smith-Hicks, Shoaib Chowdhury, Walter Kaufmann, Dietmar Kuhl, Alexey G Ryazanov,[...]. Neuron 2008
393
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.